tbuckley/cabot-search huggingface dataset:
A phase I study of lapatinib and topotecan in patients with solid tumors
Authors: J. R. Molina, C. Erlichman, S. Kaufmann, A. Adjei, S. Rubin, R. Friedman, J. Reid, R. Qin, S. Felten
Journal: Journal of Clinical Oncology (2007)

3598 Background: Drug resistance to topotecan can be the result of BCRP/ABCG2 expression. BCRP is a member of the ABC transporter family that pumps anticancer drugs out of the cell. Lapatinib is a potent and selective dual inhibitor of epidermal growth factor receptor (EGFR or ErbB1) and ErbB2 (Her2/Neu). 4-aminoquinazoline tyrosine kinase inhibitors have been shown to enhance the cytotoxicity of topotecan through inhibition of BCRP-mediated drug efflux in cancer cells. Methods: Thirty-seven patients with advanced stage cancers were enrolled at escalating dose levels of lapatinib and topotecan in cohorts IA, IB and IIB (MTD). Treatment schedule included lapatinib (750 - 1500 mg/d) daily for 21 (cohort IA) or 28 days (cohort IB) and topotecan (2.4 - 4.0 mg/ m 2 ), days 1, 8 and 15; cycles were repeated every 28 days. Three patients were treated at each dose level, 18 on cohort IA, 9 on cohort IB and 10 at MTD (cohort IIB). Assessments of toxicity were performed with each cycle and clinical response was determined per RECIST criteria every other cycle. Results: The MTD for cohorts IA and IB was reached at a dose of 1250 mg of lapatinib and 3.2 mg/m 2 of IV topotecan on days 1, 8 and 15. No DLT were seen during the dose escalation stage of cohorts IA and IB. Ten patients were enrolled at the MTD. There were no grade 4+ events. Thirteen grade 3+ events, considered to be related to treatment, were seen in 6 patients. The most common grade 3+ toxicities included dehydration (2) diarrhea (2), nausea (3), vomiting (2), neutropenia (1), thrombocytopenia (1), and fatigue (1). No abnormalities in left ventricular ejection fraction were noted. Stable disease was seen in 46% of the 37 patients. Conclusions: The combination of lapatinib and topotecan is a well-tolerated regimen. The MTD for the combination is lapatinib 1,250 mg orally once daily for 21 or 28 days and topotecan 3.2 mg/m 2 on days 1, 8 and 15. Pharmacokinetic analysis for drug interaction will be available for presentation at the meeting. Supported in part by GSK and Mayo Clinic No significant financial relationships to disclose.
Complete Molecular and Hematologic Response in Adult Patients with Relapsed/Refractory (R/R) Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia (ALL) Following Treatment with Blinatumomab: Results from a Phase 2 Single-Arm, Multicenter Study (ALCANTARA)
Authors: Giovanni Martinelli, Hervé Dombret, Patrice Chevallier, Oliver G. Ottmann, Nicola Goekbuget, Max S. Topp, Adele K. Fielding, Lulu Ren Sterling, Jonathan Benjamin, Anthony Selwyn Stein
Journal: Blood (2015)
PS01.67: Case Series of MET Exon 14 Skipping Mutation-Positive Non–Small Cell Lung Cancers and Response to Crizotinib
Authors: Samantha X. Wang, Bing M. Zhang, Heather Wakelee, Maximilian Diehn, Christian A. Kunder, Joel W. Neal
Journal: Journal of Thoracic Oncology (2016)
Tumor-Derived Chaperone-Rich Cell Lysate (CRCL) Can Be Effectively Combined with Syngeneic Bone Marrow Transplantation to Treat Bcr-abl+ Leukemia in a Murine Model.
Authors: Xinchun Chen, Yi Zeng, Gang Li, Sylvia Thompson, Marjan Sepassi, M. Angela Romanoski, Michael W. Graner, Emmanuel Katsanis
Journal: Blood (2004)
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment
Authors: Annapoorna S. Kini, Yuliya Vengrenyuk, Khader Shameer, Akiko Maehara, Meerarani Purushothaman, Takahiro Yoshimura, Mitsuaki Matsumura, Melissa Aquino, Nezam Haider, Kipp W. Johnson, Ben Readhead, Brian A. Kidd, Jonathan E. Feig, Prakash Krishnan, Joseph Sweeny, Mahajan Milind, Pedro Moreno, Roxana Mehran, Jason C. Kovacic, Usman Baber, Joel T. Dudley, Jagat Narula, Samin Sharma
Journal: Journal of the American College of Cardiology (2016)
Outbreak of Influenza A(H3N2) Variant Virus Infections Among Persons Attending Agricultural Fairs Housing Infected Swine — Michigan and Ohio, July–August 2016
Authors: Rebekah S. Schicker, John Rossow, Seth Eckel, Nicolas Fisher, Sally Bidol, Lilith Tatham, Janice Matthews-Greer, Kevin Sohner, Andrew S. Bowman, James Avrill, Tony Forshey, Lenee Blanton, C. Todd Davis, John Schiltz, Susan Skorupski, LaShondra Berman, Yunho Jang, Joseph S. Bresee, Stephen Lindstrom, Susan C. Trock, David Wentworth, Alicia M. Fry, Sietske de Fijter, Kimberly Signs, Mary DiOrio, Sonja J. Olsen, Matthew Biggerstaff
Journal: MMWR Morbidity and Mortality Weekly Report (2016)

On August 3, 2016, the Ohio Department of Health Laboratory reported to CDC that a respiratory specimen collected on July 28 from a male aged 13 years who attended an agricultural fair in Ohio during July 22-29, 2016, and subsequently developed a respiratory illness, tested positive by real-time reverse transcription-polymerase chain reaction (rRT-PCR) for influenza A(H3N2) variant* (H3N2v). The respiratory specimen was collected as part of routine influenza surveillance activities. The next day, CDC was notified of a child aged 9 years who was a swine exhibitor at an agricultural fair in Michigan who became ill on July 29, 2016, and tested positive for H3N2v virus at the Michigan Department of Health and Human Services Laboratory. Investigations by Michigan and Ohio health authorities identified 18 human infections linked to swine exhibits at agricultural fairs. To minimize transmission of influenza viruses from infected swine to visitors, agricultural fair organizers should consider prevention measures such as shortening the time swine are on the fairgrounds, isolating ill swine, maintaining a veterinarian on call, providing handwashing stations, and prohibiting food and beverages in animal barns. Persons at high risk for influenza-associated complications should be discouraged from entering swine barns.
TCT-734 Evolution of Clinical Outcomes in Patients with Aortic stenosis treated with Transcatheter Aortic Valve Replacement Across Generation of Devices
Authors: Sang Yeub Lee, Arie Steinvil, Toby Rogers, Sarkis Kiramijyan, Edward Koifman, Smita I. Negi, Joelle S. Salmon, Rebecca Torguson, Itshac Itsik Ben-dor, Hector M. Garcia-Garcia, Lowell Satler, Augusto Pichard, Ron Waksman
Journal: Journal of the American College of Cardiology (2016)
A Targeted Next-Generation Sequencing Mutation Panel for Pediatric Acute Myeloid Leukemia and Myelodysplastic Syndrome (MDS) Detects Potential Additional Driver Mutations in Pediatric GATA2-MDS
Authors: Kevin E Fisher, Hadi Sayeed, Dolores Lopez-Terrada, Alison A Bertuch, Maria Monica Gramatges
Journal: Blood (2015)
TCT-616 Medium-term Safety and Efficacy of Left Atrial Appendage Closure using the WATCHMAN®-Device in 260 Patients from Single Center
Authors: Jiangtao Yu, Lisheng Jiang, Xin Xue, Shaofeng Guan, Horst Huemmer, Fanzhou Cheng, Laszlo Halmagyi, Manuela Muenzel, Thorsten Keil, Erich Dünninger
Journal: Journal of the American College of Cardiology (2016)
Could Cobalamin Deficiency Mimic a Clonal Aberration Cytogenetic? a Case Report
Authors: Marcelo Bellesso, Daniela Ferreira Dias, Renato Torrescasana Centrone, Laura Yolanda Chialanza Garcia, Annelise Correa Wengerkievicz Lopes, Rodrigo Santucci, Ana Paula Almeida Rocha Teixeira Pinto, Leniza Pola Silva, Veronica Ramos Souza Oliveira
Journal: Blood (2014)
Observing patients with advanced non-small cell lung cancer (NSCLC): An overview of real world treatments and outcomes in Europe
Authors: H. G. Bischoff, H. Anderson, B. van den Borne, F. Langer, M. I. Leschinger, C. Moneley, F. Pimentel, H. Riska, N. Thatcher, M. Thomas
Journal: Journal of Clinical Oncology (2007)

7626 Background: ACTION (Assessment of Costs and ouTcomes of chemotherapy In an Observational setting in patients with advanced NSCLC) is a prospective, pan-European observational study. The objective of ACTION is to describe advanced NSCLC treatment in routine clinical practice. Methods: Chemonaive patients (pts) aged = 18 yrs with stage IIIb/IV NSCLC were observed for 18 months from presentation for initiation of chemotherapy (CT). All pt care, including CT given, was at the discretion of the pt/physician. Pts were excluded if participating in a clinical trial. Results: 975 pts [Germany (571), UK (193), Finland (99), Netherlands (76), Portugal (36)] were enrolled from April 2003 to September 2004 and observations completed June 2006. Median age was 65 yrs (32–90) with 28.3% of pts aged =70 yrs; 71.3% were male; 65.2% had stage IV disease. WHO performance status (PS) was 0/1 (86.2%), 2 (10.0%), 3/4 (3.8%). Of 487 pts who experienced weight loss, 172 (33.4%) lost &gt;10% body weight in 4 weeks prior to start of CT. First-line CT given: gemcitabine (gem) 10.3%, vinorelbine (vin) 4.3%, gem+platinum 45.0%, vin+platinum 14.6%, taxane+platinum 11.7%, other 14.2%. Complete response (CR) to first-line CT was observed in 1.8% of pts, partial response (PR) 37.9%, stable disease (SD) 28.5%, progressive disease (PD) 17.8%, unknown 13.8%. Second-line CT was planned for 29.2% (285) pts. Median time from initiation of 1st-line to initiation of 2nd-line CT was 5.8 months. Median age was 62 yrs (32–84); 69.8% were male; WHO PS at initiation of 2nd line CT: 0/1 (79%), 2 (17%), 3/4 (4%). Best response to 2nd-line CT: CR 0.4%, PR 9.1%, SD 19.3%, PD 48.8%, unknown 14.3%. Unadjusted median survival time for all pts: 9.3 months (95% CI 8.6–10.3). Overall estimated 1-yr survival was 39.5%. Conclusions: ACTION was the first large-scale observational study in pts with advanced NSCLC in Europe. Overall response rates and survival were consistent with clinical trial results, even though approximately one- third of pts enrolled may have been excluded from clinical trials on the basis of their baseline demographics. No significant financial relationships to disclose.
TCT-600 Impact of myocardial bridging on atherosclerotic plaque vulnerability assessed by OCT
Authors: Ryotaro Yamada, Teruyoshi Kume, Yutaka Goryo, Terumasa Koyama, Kenzo Fukuhara, Yasuhiko Kamata, Yusuke Kobayashi, Hiroshi Okamoto, Yoji Neishi, Shiro Uemura
Journal: Journal of the American College of Cardiology (2016)
Cancer Drugs Fund: the bigger picture
Authors: Carole M Longson, Linda J Landells, Elisabeth George, Meindert Boysen, Andrew Dillon
Journal: BMJ (2016)

We welcome the authors’ creative ideas on the appraisal of cancer drugs.1 But they are wrong to imply that the Cancer Drugs Fund exists only to support observational data collection.2

With the drug industry playing its part through fair pricing, patients can access NICE recommended treatments up to 8 …
TCT-338 Clinical Implications of the Residual SYNTAX Score after Percutaneous Coronary Intervention in patients with Chronic Total Occlusion and Multi-vessel Coronary Artery Disease: A Comparison with Coronary Artery Bypass Grafting
Authors: Woo Jin Jang, Jeong Hoon Yang, Seung-Hyuck Choi, Joo-Yong Hahn, Hyeon-Cheol Gwon
Journal: Journal of the American College of Cardiology (2016)
Judging the Past: How History Should Inform Bioethics
Authors: Michele A. Riva
Journal: Annals of Internal Medicine (2016)

Letters1 November 2016Judging the Past: How History Should Inform BioethicsMichele A. Riva, MD, PhDMichele A. Riva, MD, PhDFrom University of Milano Bicocca, Monza, Italy.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L16-0331 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I read Lerner and Caplan's article on the importance of a less moralistic historical approach in analyzing some past bioethical scandals (1) with interest. I particularly appreciate the examples that they provided and agree with their conclusions that “learning how societal values, scientific zeal, ideological beliefs, and the desire for personal achievement influenced [researchers who made dubious ethical choices] reveals how similar factors can and often still remain in play, even in our supposedly more “enlightened” era (1). History has many things to teach medical students and physicians, even though Whig historians in past decades have sometimes ...Reference1. Lerner BH, Caplan AL. Judging the past: how history should inform bioethics. Ann Intern Med. 2016;164:553-7. [PMID: 27089070]. doi:10.7326/M15-2642 LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From University of Milano Bicocca, Monza, Italy.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L16-0331. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoJudging the Past: How History Should Inform Bioethics Barron H. Lerner and Arthur L. Caplan Judging the Past: How History Should Inform Bioethics David A. Gorelick Judging the Past: How History Should Inform Bioethics Barron H. Lerner and Arthur L. Caplan Metrics Cited byBiases, Barriers, and Possible Solutions: Steps Towards Addressing Autism Researchers Under-Engagement with Racially, Ethnically, and Socioeconomically Diverse Communities 1 November 2016Volume 165, Issue 9Page: 675KeywordsBioethicsConflicts of interestDisclosureHistory of medicineMedical education ePublished: 1 November 2016 Issue Published: 1 November 2016 Copyright & PermissionsCopyright © 2016 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Rise of the machines
Authors: Navjoyt Ladher
Journal: BMJ (2016)

Computers replacing doctors may seem like science fiction, but our Feature this week on the potential of machine learning in healthcare suggests it is closer than we might think (doi:10.1136/bmj.i5680).The Google owned company DeepMind is working with several NHS hospitals to develop a range of diagnostic tools.For this it needs (and has been given access to) patients' data, prompting questions about whether patient consent and public awareness have been adequate for a third party to use NHS records in this way.What assurances do we have that DeepMind won't share these data with its parent company?In response, DeepMind is reviewing its processes and seeking input from patients (http://bit.ly/2eNn292).We would welcome your views in a rapid response to this article.
TCT-16 Patient and Procedural Characteristics and In-Hospital Outcomes Associated With the Use of Retrograde Recanalization Techniques for Chronic Total Occlusion PCI: A Report from the Open CTO Registry
Authors: Sanjog Kalra, James Sapontis, Robert Riley, Mohammed Qintar, Philip Jones, Ajay Kirtane, Manish Parikh, Jeffrey Moses, Ziad Ali, William Lombardi, William Nicholson, J. Aaron Grantham, Dimitri Karmpaliotis
Journal: Journal of the American College of Cardiology (2016)
TCT-502 Detection of Valve Thrombosis of Transcatheter Aortic Valve Replacement by 4D-Computed Tomography
Authors: Ambarish Gopal, Elizabeth Holper, Deepika Gopal, Alicia Avila, Marina Lovil, Heike Baumgarten, Katherine Hebeler, A. Cecile Mahoney, Molly Szerlip, Srinivasa Potluri, David L. Brown, Paul Grayburn, Michael Mack
Journal: Journal of the American College of Cardiology (2016)
TCT-670 Optimal Transcatheter Heart Valve Sizing in Aortic Valve in Valve Implantation: Insights from the Valve in Valve International Data (VIVID) Registry
Authors: Sami Alnasser, Asim Cheema, Eric Horlick, Nicolas Van Mieghem, Gudrun Feuchtner, Matheus Simonato dos Santos, Tanja Rudolph, Stephen Brecker, Pedro A. Lemos, Nicolo Piazza, Anibal Damonte, Malek Kass, David Jochheim, Julinda Mehilli, Raffi Bekeredjian, James McCabe, Axel Linke, Felix Woitek, Lars Sondergaard, Nikolaos Bonaros, Ole De Backer, Stephan Ensminger, Hardy Baumbach, Jochen Wöhrle, Joachim Schofer, Marc Pelletier, John Webb, Danny Dvir
Journal: Journal of the American College of Cardiology (2016)
Polyglycolic Acid Mesh in Distal Pancreatectomy
Authors: Yen-Yi Juo, O. Joe Hines
Journal: JAMA Surgery (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
TCT-125 Use of a Mechanical Compression Device Increases Return of Spontaneous Circulation in Patients with Cardiac Arrest in the Cardiac Catheterization Laboratory
Authors: Joseph Venturini, Elizabeth Retzer, Raider Estrada, Janet Friant, David Beiser, Dana Edelson, Jonathan Paul, John Blair, Sandeep Nathan, Atman Shah
Journal: Journal of the American College of Cardiology (2016)
Specific NK Cell Activation to Treat Relapsed/Refractory (r/r) Hodgkin Lymphoma (HL) Patients – Final, Updated Data on Clinical Outcome, Pharmacokinetics and Pharmacodynamics of a Phase 1 Study Investigating AFM13, a Bispecific Anti-CD30/CD16A Tandab
Authors: Achim Rothe, Stephanie Sasse, Max S. Topp, Dennis A. Eichenauer, Bastian von Tresckow, Horst-Dieter Hummel, Miroslav Ravic, Jens-Peter Marschner, Andreas Engert
Journal: Blood (2014)
Quality-of-life and health utility scores for common cancers in China: a multicentre cross-sectional survey
Authors: Ju-Fang Shi, Hui-Yao Huang, Lan-Wei Guo, Dian Shi, Xiu-Ying Gu, Han Liang, Le Wang, Jian-Song Ren, Ya-Na Bai, A-Yan Mao, Guo-Xiang Liu, Xian-Zhen Liao, Kai Zhang, Jie He, Min Dai
Journal: The Lancet (2016)
TCT-226 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab (TOLEDO 1)
Authors: Jose Moreu Burgos, Belen Santos Gonzalez, Tomas Canton, Ester Lazaro-Fernandez, Mar Cespedes Mas, Daniel Nuñez Peras, Luis Manuel Hernando Romero, Maria Arjona Arjona, Andres Sanchez Perez, Cristina Martin Sierra, Luis Rodriguez Padial
Journal: Journal of the American College of Cardiology (2016)
TCT-223 A randomized, placebo controlled, double-blind, phase 4 study to evaluate efficacy and safety of triple anti-platelet therapy compared with dual antiplatelet therapy in patients treated with drug-eluting stent for coronary artery disease
Authors: Cheol Hyun Lee, Osung Kwon, Ungjeong Do, Jung Ae Hong, Kyusup Lee, Min Soo Cho, B.A.E. Jaeseok, Do-yoon Kang, Se Hun Kang, Pil Hyung Lee, Sung-Han Yoon, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park
Journal: Journal of the American College of Cardiology (2016)
Microrna Profiling Classifies Acute Leukemias of Ambiguous Lineage As Either Acute Myeloid Leukemia or Acute Lymphoid Leukemia
Authors: David C. de Leeuw, Willemijn de van den Ancker, Fedor Denkers, Renee X. de Menezes, Theresia M. Westers, Gert J. Ossenkoppele, Arjan A. Van de Loosdrecht, Linda Smit
Journal: Blood (2012)
TCT-55 Risk–Benefit Analysis of Upstream Antithrombotic Therapy in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography
Authors: Bjorn Redfors, Philippe Généreux, Ajay Kirtane, Stuart Pocock, Girma Ayele, Makis Deliargyris, Roxana Mehran, Gregg Stone
Journal: Journal of the American College of Cardiology (2016)
CROMOENDOSCOPIA VIRTUAL CON NBI Y LUZ BLANCA, ESTUDIO ALEATORIZADO EN TÁNDEM EN PACIENTES CON LESIONES SERRADAS
Authors: F Riu Pons, M Andreu, D Naranjo, MA Álvarez, A Seoane, JM Dedeu, L Barranco, X Bessa
Journal: Endoscopy (2016)

La detección de pólipos serrados (PS) es difícil debido a su morfología y apariencia. Una correcta identificación conduciría al diagnóstico de un síndrome de poliposis serrada (SPS), entidad que requiere un seguimiento muy estrecho por el mayor riesgo de cáncer colorrectal.
Small Noncleaved Cell Lymphoma in Adults
Authors: Timothy M. Lopez, Fredrick B. Hagemeister, Peter McLaughlin, William S. Velasquez, Forrest Swan, John R. Redman, Maria A. Rodriguez, Susan L. Tucker, Karen Silvermintz, Jana Johnson, Fernando Cabanillas
Journal: Journal of Clinical Oncology (1994)

Table 2 in the 1990 report entitled "Small Noncleaved Cell Lymphoma in Adults: Superior Results for Stages I–III Disease" by Lopez et al (J Clin Oncol 8:615–622, 1990) contained a vincristine dosage error. The table is reprinted here correctly in its entirety. Please see the PDF for Table.
ENCUESTA NACIONAL ESPAÑOLA SOBRE PANCREATITIS AGUDA POST-CPRE (PAP): RESULTADOS Y GRADO DE CUMPLIMIENTO DE LAS GUÍAS CLÍNICAS
Authors: JM Riesco López, M Pérez Miranda, F González Huix, A Álvarez Delgado, F Pérez Roldán, J Gornals Soler, L López Roses, A Naranjo Rodriguez, C Guarner Argente, J García Cano
Journal: Endoscopy (2016)

Introducción: La pancreatitis aguda post-CPRE (PAP) es la complicación grave más frecuente asociada a este procedimiento. Las guías clínicas ofrecen diferentes recomendaciones para reducir la incidencia y gravedad de PAP.
Cytogenetic Features and Prognosis of 943 South American Patients with De Novo Myelodysplastic Syndromes: A Multicenter Study
Authors: Carolina Belli, Ronald Feitosa Pinheiro, Silvia M. M. Magalhaes, Jacqueline Gonzalez, Marcelo Iastrebner, Maria Virginia Prates, Silvia Benasayag, Yesica Bestach, Juliana Cordeiro, Marcela Cavalcante de Andrade Silva, Roberta da Silva Tanizawa, Raquel M Bengió, Cecilia Lang, Elsa Nucifora, Irene B Larripa, Elvira RP Velloso
Journal: Blood (2014)
TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials
Authors: Jaya Chandrasekhar, Bjorn Redfors, Philippe Généreux, Ajay Kirtane, Rupa Parvataneni, Roxana Mehran, Gregg Stone
Journal: Journal of the American College of Cardiology (2016)
Safety and Efficacy of Fludarabine Plus Mitoxantrone (FM) Followed by Yttrium-90 (90Y) Ibritumomab Tiuxetan (Zevalin®) and Maintenance Rituximab in Intermediate- to High-Risk Newly Diagnosed and Relapsed Follicular Non-Hodgkin’s Lymphoma (NHL).
Authors: Stephanie A. Gregory, Parameswaran Venugopal, Jamile M. Shammo, Teresa M. O’Brien, Amjad Ali
Journal: Blood (2005)